Relationship between immune-related adverse events and treatment effectiveness in extensive disease small cell lung cancer.

Keiki Yokoo, Yauo Kitamura,Keito Suzuki, Kohei Morikawa, Takeo Sawai, Hiroyuki Honda, Sayaka Kudo,Gen Yamada

Thoracic cancer（2023）

引用 2|浏览0

暂无评分

摘要

In this study, the development of irAEs did not affect OS in patients with ED-SCLC who received platinum-based agents, etoposide, or ICI therapy. We determined that managing irAEs and administering first- and second-line therapies could contribute to prolonged OS.

查看译文

关键词

cell lung cancer,lung cancer,treatment effectiveness,immune‐related

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要